Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nr-CWS for erosive oral lichen planus
ChiCTR1900022245Phase 4Recruiting
- Sponsor
- Peking University School and Hospital of Stomatology
- Start
- Apr 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nocardia rubra cell wall skeleton in oral lichen planus (OLP) (2 arms), sponsored by Peking University School and Hospital of Stomatology. Primary endpoint: Visual analogue scale. Started Apr 2019; status: recruiting.
02
Drugs
nocardia rubra cell wall skeleton
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on ChiCTR1900022245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022245.